Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Tumor immune microenvironment in head and neck cancers.
Chen SMY, Krinsky AL, Woolaver RA, Wang X, Chen Z, Wang JH. Chen SMY, et al. Among authors: chen z. Mol Carcinog. 2020 Jul;59(7):766-774. doi: 10.1002/mc.23162. Epub 2020 Feb 3. Mol Carcinog. 2020. PMID: 32017286 Free PMC article. Review.
HDAC inhibitors overcome immunotherapy resistance in B-cell lymphoma.
Wang X, Waschke BC, Woolaver RA, Chen SMY, Chen Z, Wang JH. Wang X, et al. Among authors: chen z, chen smy. Protein Cell. 2020 Jul;11(7):472-482. doi: 10.1007/s13238-020-00694-x. Epub 2020 Mar 11. Protein Cell. 2020. PMID: 32162275 Free PMC article. Review.
Differences in TCR repertoire and T cell activation underlie the divergent outcomes of antitumor immune responses in tumor-eradicating versus tumor-progressing hosts.
Woolaver RA, Wang X, Krinsky AL, Waschke BC, Chen SMY, Popolizio V, Nicklawsky AG, Gao D, Chen Z, Jimeno A, Wang XJ, Wang JH. Woolaver RA, et al. Among authors: chen smy. J Immunother Cancer. 2021 Jan;9(1):e001615. doi: 10.1136/jitc-2020-001615. J Immunother Cancer. 2021. PMID: 33414263 Free PMC article.
Differential responses to immune checkpoint inhibitor dictated by pre-existing differential immune profiles in squamous cell carcinomas caused by same initial oncogenic drivers.
Chen SMY, Popolizio V, Woolaver RA, Ge H, Krinsky AL, John J, Danis E, Ke Y, Kramer Y, Bian L, Nicklawsky AG, Gao D, Liu S, Chen Z, Wang XJ, Wang JH. Chen SMY, et al. J Exp Clin Cancer Res. 2022 Apr 2;41(1):123. doi: 10.1186/s13046-022-02337-x. J Exp Clin Cancer Res. 2022. PMID: 35366939 Free PMC article.
Divergent outcomes of anti-PD-L1 treatment coupled with host-intrinsic differences in TCR repertoire and distinct T cell activation states in responding versus non-responding tumors.
John J, Woolaver RA, Popolizio V, Chen SMY, Ge H, Krinsky AL, Vashisht M, Kramer Y, Chen Z, Wang JH. John J, et al. Among authors: chen smy. Front Immunol. 2022 Oct 18;13:992630. doi: 10.3389/fimmu.2022.992630. eCollection 2022. Front Immunol. 2022. PMID: 36330507 Free PMC article.
Enhanced Cross-Reactive and Polyfunctional Effector-Memory T Cell Responses by ICVAX-a Human PD1-Based Bivalent HIV-1 Gag-p41 Mosaic DNA Vaccine.
Chen SMY, Wong YC, Yim LY, Zhang H, Wang H, Lui GCY, Li X, Tang X, Cheng L, Du Y, Peng Q, Wang J, Kwok HY, Huang H, Lau TT, Chan DPC, Wong BCK, Liu L, Chakrabarti LA, Lee SS, Chen Z. Chen SMY, et al. J Virol. 2022 Apr 13;96(7):e0216121. doi: 10.1128/jvi.02161-21. Epub 2022 Mar 17. J Virol. 2022. PMID: 35297660 Free PMC article.
16 results